It was shown that patients with GBM have changes in the isoforms of ATP1B2 (Rotoli et al., 2017) and that targeting ATP1B2 induced glioblastoma cells apoptosis (Li et al., 2019). Here, ATP1B2 is linked to glioblastoma.